Silence Therapeutics (SLN) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free SLN Stock Alerts $22.95 +0.35 (+1.55%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVivo Capital LLC Invests $8.86 Million in Silence Therapeutics plc (NASDAQ:SLN)marketbeat.com - May 9 at 10:39 AMSilence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conferencebusinesswire.com - April 30 at 8:30 AMSilence Therapeutics Announces Retirement of Alistair Gray from Board of Directorsbusinesswire.com - April 29 at 8:30 AMVivo Capital LLC Buys 595,250 Shares of Silence Therapeutics plc (NASDAQ:SLN)marketbeat.com - April 27 at 9:40 PMSilence Therapeutics (NASDAQ:SLN) Receives Overweight Rating from Morgan Stanleymarketbeat.com - April 22 at 2:24 PMSilence Therapeutics (NASDAQ:SLN) Trading Up 3.2%marketbeat.com - April 16 at 2:02 PMA youth's call to action on this Day of NO Silenceyahoo.com - April 13 at 2:08 AMSilence Therapeutics plc (NASDAQ:SLN) Short Interest Updatemarketbeat.com - April 12 at 10:21 PMSilence Therapeutics (NASDAQ:SLN) Sees Strong Trading Volumemarketbeat.com - April 11 at 2:49 PM3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024investorplace.com - April 11 at 12:24 PMSilence Therapeutics (NASDAQ:SLN) Stock Price Down 4.5%marketbeat.com - April 9 at 2:46 PMSilence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)businesswire.com - April 8 at 11:48 AMThe Lady of Silence: The Mataviejitas Murders Streaming: Watch & Stream Online via Netflixyahoo.com - April 1 at 10:11 AM7 Biotech Stocks Ready to Ride the Sector's Resurgenceinvestorplace.com - March 18 at 8:01 PMSilence Therapeutics (NASDAQ:SLN) Price Target Raised to $42.00 at Chardan Capitalmarketbeat.com - March 18 at 5:52 PMSilence Therapeutics (NASDAQ:SLN) Shares Gap Up to $22.84marketbeat.com - March 18 at 11:23 AMAnalysts Are Upgrading Silence Therapeutics plc (NASDAQ:SLN) After Its Latest Resultsfinance.yahoo.com - March 16 at 10:20 AMSilence Therapeutics plc (SLN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 15 at 5:54 PMSilence Therapeutics (NASDAQ:SLN) Stock Price Down 5.5%marketbeat.com - March 15 at 12:59 PMSilence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 12:53 PMSilence Therapeutics plc (NASDAQ:SLN) Sees Large Growth in Short Interestmarketbeat.com - March 14 at 11:38 PMSilence Therapeutics (NASDAQ:SLN) Hits New 12-Month High at $27.72marketbeat.com - March 14 at 11:17 AMLocal authors 'Break the Silence' with book anthology to share the stories of survivorsyahoo.com - March 13 at 1:14 PMSingTel looking to sell significant Optus stake to Brookfield - sourcesg.finance.yahoo.com - March 13 at 1:14 PMSilence Therapeutics (NASDAQ:SLN) Shares Gap Down to $25.90marketbeat.com - March 13 at 12:55 PMSilence Therapeutics plc 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 13 at 7:52 AMSilence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlightsbusinesswire.com - March 13 at 7:05 AMSilence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)businesswire.com - March 13 at 7:00 AMSilence Therapeutics earnings: here's what Wall Street expectsmarkets.businessinsider.com - March 12 at 10:34 AMSilence Therapeutics (NASDAQ:SLN) Sets New 12-Month High at $26.74marketbeat.com - March 5 at 12:13 PMSilence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024finance.yahoo.com - February 28 at 10:04 AMSilence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024businesswire.com - February 28 at 8:00 AMSilence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Lookseekingalpha.com - February 24 at 8:53 PMSilence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trialbusinesswire.com - February 23 at 8:00 AMAnalysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN) and Aurinia Pharmaceuticals (AUPH)markets.businessinsider.com - February 22 at 10:22 AMSilence Therapeutics (NASDAQ:SLN) Sets New 52-Week High at $25.00marketbeat.com - February 21 at 10:47 AMRecursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?finance.yahoo.com - February 16 at 8:54 AMSilence Therapeutics PLC (SLN)investing.com - February 12 at 10:57 PMSilence Therapeutics (NASDAQ:SLN) Shares Up 1.9%marketbeat.com - February 5 at 2:36 PMSilence Therapeutics Announces Oversubscribed $120 Million Private Placementfinance.yahoo.com - February 5 at 9:03 AMSilence Therapeutics (NASDAQ:SLN) Reaches New 1-Year High at $24.33marketbeat.com - January 31 at 10:45 AMSilence Therapeutics (NASDAQ:SLN) Now Covered by BMO Capital Marketsmarketbeat.com - January 31 at 8:12 AMSilence Therapeutics (NASDAQ:SLN) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - January 18 at 8:17 AMSolid Financial Status and Promising Clinical Trial Results Drive Buy Rating for Silence Therapeuticsmarkets.businessinsider.com - November 27 at 1:00 PMSilence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenuesfinance.yahoo.com - November 27 at 8:00 AMEuropean Equities Traded in the US as American Depositary Receipts End Rough Week Lower Fridaymsn.com - October 21 at 12:03 PMThe Silence of the Lambs: Where to Watch & Stream Onlineyahoo.com - September 18 at 3:03 PMMeghan Markle's silence will benefit Kate Middleton by giving her 'unique platform' backmirror.co.uk - July 30 at 8:45 AMJamie Foxx shares reason behind silence as he says he 'knows a lot of people were waiting'mirror.co.uk - July 30 at 8:45 AMSilence Therapeutics: No Reason For It To Fall So Muchmsn.com - July 14 at 11:06 PM Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide SLN Media Mentions By Week SLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼1.790.43▲Average Medical News Sentiment SLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼11▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CVAC News PAHC News ORIC News LYEL News PHAR News ZYME News BCYC News NUVB News NRIX News OLMA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
